dalteparin has been researched along with Atrial Flutter in 3 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Atrial Flutter: Rapid, irregular atrial contractions caused by a block of electrical impulse conduction in the right atrium and a reentrant wave front traveling up the inter-atrial septum and down the right atrial free wall or vice versa. Unlike ATRIAL FIBRILLATION which is caused by abnormal impulse generation, typical atrial flutter is caused by abnormal impulse conduction. As in atrial fibrillation, patients with atrial flutter cannot effectively pump blood into the lower chambers of the heart (HEART VENTRICLES).
| Excerpt | Relevance | Reference |
|---|---|---|
| "125 patients treated as inpatients for atrial fibrillation or -flutter received the LMWH Fragmin (dalteparin 2 x 100 anti-Xa units/kg, maximum dosage 2 x 10,000 anti-Xa units subcutaneously)." | 9.10 | Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin) in atrial fibrillation and TEE-guided cardioversion. ( Bechtold, H; Fung, S; Gunzenhauser, D; Janssen, D; Sawitzki, H, 2003) |
| "125 patients treated as inpatients for atrial fibrillation or -flutter received the LMWH Fragmin (dalteparin 2 x 100 anti-Xa units/kg, maximum dosage 2 x 10,000 anti-Xa units subcutaneously)." | 5.10 | Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin) in atrial fibrillation and TEE-guided cardioversion. ( Bechtold, H; Fung, S; Gunzenhauser, D; Janssen, D; Sawitzki, H, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lui, JK | 1 |
| McIntosh, LJ | 1 |
| Escobar Valle, J | 1 |
| Stockl, T | 1 |
| Summers, S | 1 |
| Lissoway, J | 1 |
| Booth, A | 1 |
| Bechtold, H | 1 |
| Gunzenhauser, D | 1 |
| Sawitzki, H | 1 |
| Fung, S | 1 |
| Janssen, D | 1 |
1 trial available for dalteparin and Atrial Flutter
| Article | Year |
|---|---|
Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin) in atrial fibrillation and TEE-guided cardioversion.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Atrial Fl | 2003 |
2 other studies available for dalteparin and Atrial Flutter
| Article | Year |
|---|---|
Facial Drooping, Aphasia, and an Incidental Lung Mass in a Nonsmoker.
Topics: Aged; Air Pollutants, Occupational; Anticoagulants; Aphasia; Atrial Flutter; Carcinoma, Squamous Cel | 2017 |
Fatal retroperitoneal hematoma after enoxaparin administration in a patient with paroxysmal atrial flutter.
Topics: Anticoagulants; Atrial Flutter; Chest Pain; Enoxaparin; Fatal Outcome; Female; Hematoma; Humans; Mid | 2010 |